The grants for research projects on rare diseases within the Framework Program for Cutting-Edge Health in 2024 are an initiative of the Ministry of Science, Innovation and Universities, managed through the Carlos III Health Institute (ISCIII). This call, endowed with 20 million euros, is designed to promote research and innovation in the healthcare sector, specifically in the field of rare and neuromuscular diseases, with a special emphasis on Amyotrophic Lateral Sclerosis (ALS).
These grants aim to finance projects that enable the development and implementation of clinical and care actions in the National Health System under the concept of Precision Personalized Medicine, in coordination with the IMPaCT infrastructure. The goal is to improve prevention, diagnosis, treatment, and care for patients and their families.
The subsidized projects must be of proven quality and focused on addressing unmet needs in close collaboration with the sick individuals, their representatives, and families. Additionally, those aimed at validating technologies, biomarkers, and procedures of Precision Personalized Medicine in daily clinical practice will be prioritized.
The research lines covered by the call are:
– Genomic Medicine of rare diseases, including the identification of variants and tools for prevention and early diagnosis.
– Improvement of prevention, early diagnosis, and treatment of ALS and other neuromuscular diseases.
– Research on continuity of care strategies from the hospital to primary care.
– Research on care for chronicity and disability in patients with rare diseases, ALS, and other neuromuscular diseases.
The entities that can apply for these grants include accredited health research institutes, public and private health entities, universities, public research organizations, non-profit public and private entities, public consortia, and other R&D centers with demonstrated capacities in health research.
The total budget allocated to this call is 20 million euros, with the possibility of increasing by an additional 5 million, coming from the Recovery, Transformation, and Resilience Plan.
Applications must be submitted through the electronic headquarters of the Carlos III Health Institute, between July 18 and September 5, 2024.
The Framework Program for Cutting-Edge Health, one of the 12 strategic projects of the Recovery, Transformation, and Resilience Plan, aims to transform the healthcare sector through science, innovation, and digitalization. With a planned investment of 2,358.61 million euros until 2026, this project aims to improve prevention, diagnosis, treatment, and rehabilitation in a personalized and advanced manner.
Source: Recovery Plan Government of Spain
Referrer: MiMub in Spanish
